Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Female androgen insufficiency.

Gloria Bachmann1, Deepa Oza

  • 1University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Hospital Medical School, Women's Health Institute, 125 Patterson Street, 1CAB-2104, New Brunswick, NJ 08903-2601, USA. gloria.bachmann@umdnj.edu

Obstetrics and Gynecology Clinics of North America
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous fecal microbiota transplantation restores the infant gut microbiome and metabolome after antibiotics: a case report.

mBio·2026
Same author

Factors influencing biospecimen collection in decentralized pregnancy and birth cohorts: A qualitative study.

Journal of clinical and translational science·2025
Same author

Barriers and strategies for recruitment of pregnant women in contemporary longitudinal birth cohort studies.

BMC medical research methodology·2025
Same author

Assessments of working group effectiveness in the planning of the New Jersey Kids Study: An applied mixed-methods study on the science of team science.

Journal of clinical and translational science·2024
Same author

Addressing challenges related to the professional practice of abortion post-Roe.

American journal of obstetrics and gynecology·2023
Same author

Virtual Peer Groups Reduce HbA1c and Increase Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes.

Diabetes technology & therapeutics·2023
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Female androgen deficiency (FAI) diagnosis and treatment remain challenging. Androgen therapy shows promise but lacks FDA-approved options, necessitating further research for standardized care.

Area of Science:

  • Endocrinology
  • Women's Health
  • Reproductive Medicine

Background:

  • Female androgen insufficiency (FAI) is a common condition often linked to aging and ovarian dysfunction.
  • Current diagnostic criteria and management strategies for FAI lack standardization, posing clinical challenges.
  • While androgens show therapeutic potential, specific FDA-approved preparations for women are unavailable.

Purpose of the Study:

  • To highlight the unmet needs in the diagnosis and management of FAI.
  • To underscore the importance of developing standardized approaches for FAI.
  • To emphasize the need for FDA-approved androgen therapies for women with FAI.

Main Methods:

  • This study is a review of current literature and clinical challenges regarding FAI.

Related Experiment Videos

  • It synthesizes existing knowledge on the efficacy of androgen use in women with FAI.
  • It identifies gaps in research and clinical practice.

    • Main Results:

    • Standardized diagnostic criteria for FAI are lacking.
    • Effective management protocols for FAI are not well-established.
    • There are no FDA-approved androgen preparations for treating FAI in women.

    Conclusions:

    • Significant gaps exist in the standardized diagnosis and management of FAI.
    • Further large-scale, long-term, controlled trials are essential.
    • The development and approval of androgen preparations for women with FAI are critically needed.